Smooth muscle relaxing, acute and long-term blood pressure lowering effects of atriopeptins. Structure-activity relationship

JG De Mey, C Cuthbert, KG von Szendroi, G van Malder and J Roba

The relationship between the arterial relaxing, acute and long-term blood pressure lowering effects of atriopeptins were analyzed. We therefore evaluated effects of atriopeptin (103-126), i.e., atriopeptin III, and compared them to those of selected analogs. Atriopeptin (103- 126) relaxed isolated aortas (1-30 nM) and lowered systolic blood pressure in conscious spontaneously hypertensive rats when high doses (4-400 nmol/kg i.v.) were administered acutely or low doses (0.4-4.0 nmol/kg/hr i.v.) were administered chronically. The relaxing effect was not affected by amino-terminal extension with up to four amino acids and by carboxy-terminal deletion of one amino acid. Further deletions lowered the relaxing potency. The observed maximal amplitude of the acute blood pressure lowering was reduced drastically by carboxy- terminal deletion of even one amino acid. This was prevented by substitution of the carboxy-terminal acid by an amide. Although not affecting the amplitude, amino-terminal extension with Arg or Arg-Arg prolonged markedly the duration of action of the acute effect. Chronic administration of atriopeptin (103-126), (103-125) and (103-123) affected blood pressure similarly. These findings illustrate different structure-activity relationships for the smooth muscle relaxing, acute and long-term antihypertensive activities of atriopeptins. From this it is suggested that the carboxy-terminal amino acids modulate differently the biological activities of atriopeptins, that amino-terminal amino acids modulate the duration of action of the acute in vivo effects and that the long-term antihypertensive effects of atriopeptins are not related directly to their arterial smooth muscle relaxing and acute blood pressure lowering effects.

Volume 240, Issue 3, pp. 937-943, 03/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K.-F. Lin, J. Chao, and L. Chao Human Atrial Natriuretic Peptide Gene Delivery Reduces Blood Pressure in Hypertensive Rats Hypertension, December 1, 1995; 26(6): 847 - 853. [Abstract] [Full Text]